AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human Fallopian tube
Authors: Piek, JMJ van Diest, PJ Verheijen, RHM Kenemans, P
Citation: Jmj. Piek et al., Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human Fallopian tube, HISTOPATHOL, 38(5), 2001, pp. 481-482
Survival analysis in familial ovarian cancer, a case control study
Authors: Zweemer, RP Verheijen, RHM Coebergh, JWW Jacobs, IJ van Diest, PJ Gille, JJP Skates, S Menko, FH Ten Kate, LP Kenemans, P
Citation: Rp. Zweemer et al., Survival analysis in familial ovarian cancer, a case control study, EUR J OB GY, 98(2), 2001, pp. 219-223
Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors
Authors: Van den Brande, J Panday, VRN Hoekman, K Rosing, H Huijskes, RVHP Verheijen, RHM Beijnen, JH Vermorken, JB
Citation: J. Van Den Brande et al., Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors, AM J CL ONC, 24(4), 2001, pp. 401-403
Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias
Authors: Baak, JPA Orbo, A van Diest, PJ Jiwa, M de Bruin, P Broeckaert, M Snijders, W Boodt, PJ Fons, G Burger, C Verheijen, RHM Houben, PWH The, HS Kenemans, P
Citation: Jpa. Baak et al., Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias, AM J SURG P, 25(7), 2001, pp. 930-935
Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear
Authors: Nobbenhuis, MAE Helmerhorst, TJM van den Brule, AJC Rozendaal, L Voorhorst, FJ Bezemer, PD Verheijen, RHM Meijer, CJLM
Citation: Mae. Nobbenhuis et al., Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear, LANCET, 358(9295), 2001, pp. 1782-1783
Tubal ligation and risk of ovarian cancer
Authors: Piek, JMJ van Diest, PJ Zweemer, RP Kenemans, P Verheijen, RHM
Citation: Jmj. Piek et al., Tubal ligation and risk of ovarian cancer, LANCET, 358(9284), 2001, pp. 844-844
Comparative genomic hybridization of microdissected familial ovarian carcinoma: Two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma
Authors: Zweemer, RP Ryan, A Snijders, AM Hermsen, MAJA Meijer, GA Beller, U Menko, FH Jacobs, IJ Baak, JPA Verheijen, RHM Kenemans, P van Diest, PJ
Citation: Rp. Zweemer et al., Comparative genomic hybridization of microdissected familial ovarian carcinoma: Two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma, LAB INV, 81(10), 2001, pp. 1363-1370
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
Authors: Piek, JMJ van Diest, PJ Zweemer, RP Jansen, JW Poort-Keesom, RJJ Menko, FH Gille, JJP Jongsma, APM Pals, G Kenemans, P Verheijen, RHM
Citation: Jmj. Piek et al., Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer, J PATHOLOGY, 195(4), 2001, pp. 451-456
Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
Authors: Nobbenhuis, MAE Meijer, CJLM van den Brule, AJC Rozendaal, L Voorhorst, FJ Risse, EKJ Verheijen, RHM Helmerhorst, TJM
Citation: Mae. Nobbenhuis et al., Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia, BR J CANC, 84(6), 2001, pp. 796-801
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva
Authors: de Hullu, JA Hollema, H Piers, DA Verheijen, RHM van Diest, PJ Mourits, MJE Aalders, JG van der Zee, AGJ
Citation: Ja. De Hullu et al., Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva, J CL ONCOL, 18(15), 2000, pp. 2811-2816
Human MUC1 mucin: a multifaceted glycoprotein
Authors: von Mensdorff-Pouilly, S Snijdewint, FGM Verstraeten, AA Verheijen, RHM Kenemans, P
Citation: S. Von Mensdorff-pouilly et al., Human MUC1 mucin: a multifaceted glycoprotein, INT J B MAR, 15(4), 2000, pp. 343-356
Fallopian tube cancer as a feature of BRCA1-associated syndromes - Response
Authors: Verheijen, RHM
Citation: Rhm. Verheijen, Fallopian tube cancer as a feature of BRCA1-associated syndromes - Response, GYNECOL ONC, 78(2), 2000, pp. 264-264
Ovarian cancer in female-to-male transsexuals: Report of two cases
Authors: Hage, JJ Dekker, JJML Karim, RB Verheijen, RHM Bloemena, E
Citation: Jj. Hage et al., Ovarian cancer in female-to-male transsexuals: Report of two cases, GYNECOL ONC, 76(3), 2000, pp. 413-415
Molecular evidence linking primary cancer of the Fallopian tube to BRCA1 germline mutations
Authors: Zweemer, RP van Diest, PJ Verheijen, RHM Ryan, A Gille, JJP Sijmons, RH Jacobs, IJ Menko, FH Kenemans, P
Citation: Rp. Zweemer et al., Molecular evidence linking primary cancer of the Fallopian tube to BRCA1 germline mutations, GYNECOL ONC, 76(1), 2000, pp. 45-50
Sentinel node detection in cervical cancer
Authors: Verheijen, RHM Pijpers, R van Diest, PJ Burger, CW Buist, MR Kenemans, P
Citation: Rhm. Verheijen et al., Sentinel node detection in cervical cancer, OBSTET GYN, 96(1), 2000, pp. 135-138
Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis
Authors: van Duin, M Snijders, PJF Vossen, MTM Klaassen, E Voorhorst, F Verheijen, RHM Helmerhorst, TJ Meijer, CJLM Walboomers, JMM
Citation: M. Van Duin et al., Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis, J GEN VIROL, 81, 2000, pp. 317-325
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
Authors: Bontkes, HJ de Gruijl, TD van den Muysenberg, AJC Verheijen, RHM Stukart, MJ Meijer, CJLM Scheper, RJ Stacey, SN Duggan-Keen, MF Stern, PL Man, S Borysiewicz, LK Walboomers, JMM
Citation: Hj. Bontkes et al., Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia, INT J CANC, 88(1), 2000, pp. 92-98
Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types
Authors: Jacobs, MV Walboomers, JMM Snijders, PJF Voorhorst, FJ Verheijen, RHM Fransen-Daalmeijer, N Meijer, CJLM
Citation: Mv. Jacobs et al., Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types, INT J CANC, 87(2), 2000, pp. 221-227
An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinoma
Authors: Davies, Q Perkins, AC Roos, JC Molthoff, CFM Verheijen, RHM Frier, M Kenemans, P Broadhead, T Sopwith, M Symonds, EM
Citation: Q. Davies et al., An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinoma, BR J OBST G, 106(1), 1999, pp. 31-37
CA 125: fundamental and clinical aspects
Authors: Verheijen, RHM von Mensdorff-Pouilly, S van Kamp, GJ Kenemans, P
Citation: Rhm. Verheijen et al., CA 125: fundamental and clinical aspects, SEM CANC B, 9(2), 1999, pp. 117-124
Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
Authors: de Gruijl, TD Bontkes, HJ van den Muysenberg, AJC van Oostveen, JW Stukart, MJ Verheijen, RHM van der Vange, N Snijders, PJF Meijer, CJLM Walboomers, JMM Scheper, RJ
Citation: Td. De Gruijl et al., Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix, EUR J CANC, 35(3), 1999, pp. 490-497
Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer
Authors: Nijman, HW Kenemans, P Poort-Keesom, RJJ Verstraeten, RA Mensdorff-Pouilly, S Verheijen, RHM Melief, CJM Hilgers, J Meijer, CJLM
Citation: Hw. Nijman et al., Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer, EUR J OB GY, 83(2), 1999, pp. 201-206
Differences between hereditary and sporadic ovarian cancer
Authors: Zweemer, RP Verheijen, RHM Menko, FH Gille, JJP van Diest, PJ Coebergh, JW Shaw, PA Jacobs, IJ Kenemans, P
Citation: Rp. Zweemer et al., Differences between hereditary and sporadic ovarian cancer, EUR J OB GY, 82(2), 1999, pp. 151-153
Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study
Authors: Schutter, EMJ Mijatovic, V Kok, A Van Kamp, GJ Verstraeten, R Verheijen, RHM
Citation: Emj. Schutter et al., Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study, ANTICANC R, 19(6C), 1999, pp. 5551-5557
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia
Authors: Bontkes, HJ de Gruijl, TD Bijl, A Verheijen, RHM Meijer, CJLM Scheper, RJ Stern, PL Burns, JE Maitland, NJ Walboomers, JMM
Citation: Hj. Bontkes et al., Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia, J GEN VIROL, 80, 1999, pp. 2453-2459
Risultati: 1-25 | 26-30